SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1, MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 19551958, 1996.
  • 2
    Andreoni M, Sarmati L, Ercoli L, Nicastri E, Giannini G, Galluzzo C, Pirillo MF, Vella S: Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS Res Hum Retroviruses 13: 555561, 1997.
  • 3
    Bagnarelli P, Valenza A, Menzo S, Manzin A, Scalise G, Varaldo PE, Clementi M: Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 68: 24952502, 1994.
  • 4
    Bayer JA, Bauman JGJ: Flow cytometric detection of beta-globin mRNA in murine haemopoietic tissues using flourescent in situ hybridization. Cytometry 11: 132143, 1990.
  • 5
    Blauvelt A, Clerici M, Lucey DR, Steinberg SM, Yarchoan R, Walker R, Shearer GM, Katz SI: Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 154: 35063515, 1995.
  • 6
    Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR (#RR-17) 41: 119, 1992.
  • 7
    Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 185: 621628, 1997.
  • 8
    Cornelissen M, Mulder-Kampigna G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hoek L, Sol C, Coutinho R, Goudsmit J: Syncytium-inducing SI phenotype suppression at seroconversion after intramuscular inoculation of a nonsyncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 69: 181018, 1995.
  • 9
    Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 363: 359361, 1993.
  • 10
    Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G proteincoupled receptor. Science 272: 872877, 1996.
  • 11
    Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS: Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86: 23652368, 1989.
  • 12
    Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, Fauci AS, Siebenlist UK: A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J Exp Med 180: 14451456, 1994.
  • 13
    Furtado MR, Kingsley LA, Wolinsky SM: Changes in the viral mRNA expression pattern correlate with a rapid rate of CD41 T-cell number decline in human immunodeficiency virus type 1-infected individuals. J Virol 69: 20922100, 1995.
  • 14
    Gendelman H, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lana HC, Fauci AS, Burke DS, Skillman D, Meltzer MS: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167: 14281441, 1988.
  • 15
    Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM: The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyinositol linkage. J Immunol 141: 547552, 1988.
  • 16
    Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123126, 1995.
  • 17
    Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin JM: HIV-1 in blood monocytes: Frequency of proviral DNA using PCR and comparison with total CD4 count. AIDS Res Hum Retroviruses 8: 261268, 1992.
  • 18
    Lalli E, Gibellini D, Santi S, Facchini A: In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Anal Biochem 207: 298303, 1992.
  • 19
    Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183289, 1993.
  • 20
    Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH: Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J Virol 65: 39733985, 1991.
  • 21
    McElrath MJ, Steinman RM, Cohn ZA: Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J Clin Invest 87: 2730, 1991.
  • 22
    Mosiman VL, Patterson BK, Canterero L, Goolsby CL: Reducing cellular autofluorescence in flow cytometry: An in situ method. Cytometry 30: 151156, 1997.
  • 23
    Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 11671170, 1996.
  • 24
    Meltzer MS, Gendelman HE: Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Topics Microsc Immunol 181: 239261, 1992.
  • 25
    Panteleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 363: 355358, 1993.
  • 26
    Patterson BK: PCR in situ hybridization: Applications and modifications. In: PCR In Situ Hybridization, Principles and Practice, O'LearyJJ, HerringtonCS (eds). Oxford University Press. New York, 1998.
  • 27
    Patterson BK, Goolsby C, Hodara V, Otto P, Lohman K, Wolinsky SM: Flow cytometric detection of CD41 cells harboring human immunodeficiency virus type 1 (HIV-1) DNA by dual immunophenotyping and PCR-driven in situ hybridization: Evidence of epitope masking of the CD4 cell surface molecule in vivo. J Virol 69: 43164322, 1995.
  • 28
    Patterson BK, Jiyamapa D, Mayrand PE, Hoff B, Abramson R, Garcia P: Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 58-nuclease assay (FISNA). Nucleic Acids Res 24: 36563658, 1996.
  • 29
    Patterson BK, Till M, Otto P, Goolsby C, Furtado M, McBride L, Wolinsky SM: Detection of HIV-1 DNA and mRNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260: 976979, 1993.
  • 30
    Peng H, Reinhart TA, Retzel EF, Staskus KA, Zupancic M, Haase AT: Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology 206: 1627, 1994.
  • 31
    Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271: 15821586, 1996.
  • 32
    Phillips AN: Reduction of HIV concentration during acute infection: Independence from a specific immune response. Science 271: 497499, 1996.
  • 33
    Pomerantz RJ, Trono D, Feinberg MB, Baltimore D: Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 61: 12711276, 1990.
  • 34
    Ravichandran KS, Semproni AR, Goldsby RA, Osborne BA: Immunoglobulin VH usage analysis by fluorescent in situ hybridization and flow cytometry. J Immunol Methods 153: 249259, 1992.
  • 35
    Re MC, Furlini G, Gibellini D, Vignoli M, Ramazzotti E, Lolli S, Ranieri S, La Placa M: Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometric analysis of the product of an in situ PCR assay. J Clin Microsc 32: 21522157, 1994.
  • 36
    Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA: Increased susceptability of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89: 176183, 1992.
  • 37
    Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Lane HC: Increasing viral burden in CD41 T-cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 113: 438443, 1990.
  • 38
    Schnittman SM, Psallidopoulous MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman MP, Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T-cell that maintains expression of CD4. Science 245: 305308, 1989.
  • 39
    Schuitemaker H, Koostra N, de Goede R, de Wolf R, Miedema F, Tersmette M: Monocytotropic human immunodeficiency virus type1 (HIV-1) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 65: 356363, 1991.
  • 40
    Spear GT, Ou C-Y, Kessler HA, Moore JL, Schochetman G, Landay AL: Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV-1)-infected persons for HIV DNA. J Infect Dis 162: 12391244, 1990.
  • 41
    Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of Simian immunodeficiency virus into rhesus macaques. J Exp Med 183: 215225, 1996.
  • 42
    Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA: HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J 9: 15511560, 1990.
  • 43
    Tang S, Patterson BK, Levy JA: Highly purified quiescent human peripheral blood CD41 T cells are infectable by human immunodeficiency virus but do not release virus after activation. J Virol 69: 56595665, 1995.
  • 44
    Taylor JMG, Fahey JL, Detels R, Giorgi JV: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acq Imm Def Syn 2: 114124, 1989.
  • 45
    Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N: CD14low CD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25: 34183424, 1995.
  • 46
    Turner BJ, Hecht FM, Ismail RB: CD41 T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1: A review for clinical practitioners. Arch Intern Med 154: 15611573, 1994.
  • 47
    Wei X, Ghosh SK, Taylor M, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GS: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117122, 1995.
  • 48
    Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 14311434, 1990.
  • 49
    Zerlauth G, Maier E, Chehadeh H, Zimmerman K, Eibl MM, Mannhalter JW: Interaction with human immunodeficiency virus type 1 modulates innate effector functions of human monocytes. J Infect Dis 172: 15981601, 1995.